{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:11:29Z","timestamp":1778944289471,"version":"3.51.4"},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2024,6,25]]},"DOI":"10.1253\/circj.cj-23-0613","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T22:12:54Z","timestamp":1701900774000},"page":"1107-1114","source":"Crossref","is-referenced-by-count":11,"title":["Two-Year Outcomes of Primary Prophylactic Use of Defibrillators for Ischemic and Non-Ischemic Cardiomyopathy\u3000\u2015 Propensity Score-Matched Analysis From the Nippon Storm Study \u2015"],"prefix":"10.1253","volume":"88","author":[{"given":"Yusuke","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Takanashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nitta","sequence":"additional","affiliation":[{"name":"Nippon Medical School Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Aizwa","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Tachikawa Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Ohe","sequence":"additional","affiliation":[{"name":"Okayama City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kurita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Kindai University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. <i>N Engl J Med<\/i> 1996; 335: 1933\u20131940.","DOI":"10.1056\/NEJM199612263352601"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883.","DOI":"10.1056\/NEJMoa013474"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, et al; Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Long-term benefit of primary prophylaxis with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. <i>Circulation<\/i> 2010; 122: 1265\u20131271.","DOI":"10.1161\/CIRCULATIONAHA.110.940148"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. K\u00f8ber L, Thune JJ, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, et al. Defibrillator implantation in patients with non-ischemic systolic heart failure. <i>N Engl J Med<\/i> 2016; 375: 1221\u20131230.","DOI":"10.1056\/NEJMoa1608029"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. ESC Joint Working Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. <i>Eur Heart J<\/i> 2022; 43: 3997\u20134126.","DOI":"10.1093\/eurheartj\/ehac262"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kurita T, Noda T, Nitta T, Furushima H, Shimizu A, Ohe T, et al. Nippon Storm Study design. <i>J Arrhythm<\/i> 2012; 28: 277\u2013279.","DOI":"10.1016\/j.joa.2012.04.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Noda T, Kurita T, Nitta T, Abe H, Watanabe S, Furushima H, et al. Appropriate duration of driving restrictions after inappropriate therapy from implantable cardiac shock devices: Interim analysis of the Nippon Storm Study. <i>Circ J<\/i> 2014; 78: 1989\u20131991.","DOI":"10.1253\/circj.CJ-14-0589"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011). <i>Circ J<\/i> 2013; 77: 249\u2013274.","DOI":"10.1253\/circj.CJ-66-0054"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, et al. Electrical storm presages nonsudden death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. <i>Circulation<\/i> 2001; 103: 2066\u20132071.","DOI":"10.1161\/01.CIR.103.16.2066"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. <i>N Engl J Med<\/i> 1999; 341: 1882\u20131890.","DOI":"10.1056\/NEJM199912163412503"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. B\u00e4nsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). <i>Circulation<\/i> 2002; 105: 1453\u20131458.","DOI":"10.1161\/01.CIR.0000012350.99718.AD"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. <i>N Engl J Med<\/i> 2005; 352: 225\u2013237.","DOI":"10.1056\/NEJMoa043399"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. <i>N Engl J Med<\/i> 2004; 350: 2140\u20132150.","DOI":"10.1056\/NEJMoa032423"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. <i>N Engl J Med<\/i> 2004; 350: 2151\u20132158.","DOI":"10.1056\/NEJMoa033088"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, et al. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with non-ischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia: AMIOVIRT. <i>J Am Coll Cardiol<\/i> 2003; 41: 1707\u20131712.","DOI":"10.1016\/S0735-1097(03)00297-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Elming MB, Nielsen JC, Haarbo J, Videb\u00e6k L, Korup E, Signorovitch J, et al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with non-ischemic systolic heart failure. <i>Circulation<\/i> 2017; 136: 1772\u20131780.","DOI":"10.1161\/CIRCULATIONAHA.117.028829"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management: An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. <i>Eur J Heart Fail<\/i> 2019; 21: 1169\u20131186.","DOI":"10.1002\/ejhf.1531"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B, et al. Implantable cardioverter\/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: An updated meta-analysis and systematic review of randomized controlled trials. <i>Clin Res Cardiol<\/i> 2017; 106: 501\u2013513.","DOI":"10.1007\/s00392-017-1079-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Darma A, Nedios S, Kosiuk J, Richter S, Doering M, Arya A, et al. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. <i>Europace<\/i> 2016; 18: 405\u2013412.","DOI":"10.1093\/europace\/euv138"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Shore S, Grau-Sepulveda MV, Bhatt DL, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Characteristics, treatments, and outcomes of hospitalized heart failure patients stratified by etiologies of cardiomyopathy. <i>J Am Coll Cardiol HF<\/i> 2015; 3: 906\u2013916.","DOI":"10.1016\/j.jchf.2015.06.012"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Younis A, Goldberger JJ, Kutyifa V, Kutyifa V, Zareba W, Polonsky B, et al. Predicted benefit of an implantable cardioverter-defibrillator: The MADIT-ICD benefit score. <i>Eur Heart J<\/i> 2021; 42: 1676\u20131684.","DOI":"10.1093\/eurheartj\/ehaa1057"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. <i>Circ J<\/i> 2015; 79: 381\u2013390.","DOI":"10.1253\/circj.CJ-14-0925"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Noda T, Kurita T, Nitta T, Chiba Y, Furushima H, Matsumoto N, et al. Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator. <i>Int J Cardiol<\/i> 2018; 255: 85\u201391.","DOI":"10.1016\/j.ijcard.2017.11.077"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kondo Y, Noda T, Sato Y, Ueda M, Nitta T, Aizawa Y, et al. Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: A prospective propensity score-matched analysis from the Nippon Storm Study. <i>Heart Rhythm O2<\/i> 2021; 2: 5\u201311.","DOI":"10.1016\/j.hroo.2020.12.020"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sasaki S, Noda T, Okumura K, Nitta T, Aizawa Y, Ohe T, et al. Effectiveness of implantable cardioverter defibrillator in patients with non-ischemic heart failure with systolic dysfunction: Subanalysis of the Nippon Storm Study. <i>Circ J<\/i> 2022; 87: 92\u2013100.","DOI":"10.1253\/circj.CJ-22-0187"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Evonich RF, Maheshwari A, Gardiner JC, Khasnis A, Kantipudi S, Ip JH, et al. Implantable cardioverter defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. <i>J Interv Card Electrophysiol<\/i> 2004; 11: 59\u201365.","DOI":"10.1023\/B:JICE.0000035931.10063.50"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rusnak J, Behnes M, Wei\u00df C, Nienaber C, Reiser L, Schupp T, et al. Non-ischemic compared to ischemic cardiomyopathy is associated with increasing recurrent ventricular tachyarrhythmias and ICD-related therapies. <i>J Electrocardiol<\/i> 2020; 59: 174\u2013180.","DOI":"10.1016\/j.jelectrocard.2020.02.009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rohde LE, Chatterjee NA, Vaduganathan M, Claggett B, Packer M, Desai AS, et al. Sacubitril\/valsartan and sudden cardiac death according to implantable cardioverter-defibrillator use and heart failure cause: A PARADIGM-HF analysis. <i>JACC Heart Fail<\/i> 2020; 8: 844\u2013855.","DOI":"10.1016\/j.jchf.2020.06.015"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al; JCS\/JHRS Joint Working Group. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2021; 85: 1104\u20131244.","DOI":"10.1253\/circj.CJ-20-0637"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Aonuma K, Ando K, Kusano K, Asai T, Inoue K, Inamura Y, et al. Primary results from the Japanese Heart Failure and sudden cardiac death Prevention Trial (HINODE). <i>ESC Heart Fail<\/i> 2022; 9: 1584\u20131596.","DOI":"10.1002\/ehf2.13901"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/88\/7\/88_CJ-23-0613\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T03:15:55Z","timestamp":1719630955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/88\/7\/88_CJ-23-0613\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-23-0613","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"article-number":"CJ-23-0613"}}